000 | 00818 a2200241 4500 | ||
---|---|---|---|
005 | 20250517230653.0 | ||
264 | 0 | _c20200217 | |
008 | 202002s 0 0 eng d | ||
022 | _a2151-4658 | ||
024 | 7 |
_a10.1002/acr.23714 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDaikh, David I | |
245 | 0 | 0 |
_aHow Should We Consider Lupus Without Antinuclear Antibodies? _h[electronic resource] |
260 |
_bArthritis care & research _c07 2019 |
||
300 |
_a853-854 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aAntibodies, Antinuclear |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoglobulin G |
700 | 1 | _aAringer, Martin | |
773 | 0 |
_tArthritis care & research _gvol. 71 _gno. 7 _gp. 853-854 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/acr.23714 _zAvailable from publisher's website |
999 |
_c28659095 _d28659095 |